Working… Menu

Innovative Anti-pneumococcal Vaccine Strategies in Patients With ANCA-associated Vasculitis Receiving Rituximab Therapy (PNEUMOVAS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03069703
Recruitment Status : Recruiting
First Posted : March 3, 2017
Last Update Posted : February 19, 2019
EUCLID Clinical Trials Platform
Recherche Clinique Paris Descartes Necker Cochin Sainte Anne
CIC Cochin-Pasteur
Groupe Français d'Etude des Vascularites (GFEV)
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris